ArticleApplied immunohistochemistry & molecular morphology : AIMM2019

Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab.

Eri Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.